Drawing for INTERMOUNTAIN PRECISION GENOMICS

USPTO serial 86563378

INTERMOUNTAIN PRECISION GENOMICS

Reviewed by CopyMark Law Group

Reg. 4928946Status 710
Filing date
Status date
Registration date
Mar 29, 2016
Examiner
FALK, JONATHAN ROBERT
Law office
TMO LAW OFFICE 111

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with INTERMOUNTAIN PRECISION GENOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Joshua G. Gigger

Joshua G. Gigger Stoel Rives LLP201 South Main Street, Suite 1100One Utah CenterSalt Lake City, UT 84111-2215

Goods and services

ClassDescriptionStatusFirst use
044Medical services, namely, providing personalized drug therapy management programs to cancer patients based on the patient's genetic testing results; genetic testing for medical purposes; genetic testing for cancer diagnosis and treatment purposes; providing genetic sequencing and consulting services designed to provide cancer patients and oncologists with custom tailored information about the range of possible treatments and drug therapies for a particular cancer; providing information to patients and physicians to recommend cancer treatment and drug therapies based on the patient's genetic testing results; providing personalized drug therapy services for cancer patients; drug utilization review dispensing services, namely, identifying cancer drug therapies based on a patient's genetic testing results prior to dispensing medications; developing and managing comprehensive programs involving drug therapy and physician support services in the nature of providing consultation in the dispensing of prescription drugs for persons with particular cancersSECTION 8 - CANCELLEDApr 12, 2015

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Mar 29, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Aug 1, 2022NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Aug 1, 2022C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Aug 1, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Feb 16, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Feb 4, 2022CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 4, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 4, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 4, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 4, 2022COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Mar 29, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Mar 29, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 24, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Feb 23, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 1, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jan 31, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 21, 2015IUAFUSE AMENDMENT FILED—
Dec 21, 2015EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Nov 24, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 29, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 29, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 9, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 21, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 19, 2015ALIEASSIGNED TO LIE—
Aug 4, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 23, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 22, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 22, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2015GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 12, 2015GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jun 12, 2015EPENCOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY—
Jun 12, 2015CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jun 10, 2015DOCKASSIGNED TO EXAMINER—
Mar 25, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Mar 24, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 17, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance